Literature DB >> 15506926

A molecular code for splicing silencing: configurations of guanosine-rich motifs.

P J Grabowski1.   

Abstract

Alternative pre-mRNA splicing is frequently used to expand the protein-coding capacity of genomes, and to regulate gene expression at the post-transcriptional level. It is a significant challenge to decipher the molecular language of tissue-specific splicing because the inherent flexibility of these mechanisms is specified by numerous short sequence motifs distributed in introns and exons. In the present study, we employ the glutamate NMDA (N-methyl-D-aspartate) R1 receptor (GRIN1) transcript as a model system to identify the molecular determinants for a brain region-specific exon silencing mechanism. We identify a set of guanosine-rich motifs that function co-operatively to regulate the CI cassette exon in a manner consistent with its in vivo splicing pattern. Whereas hnRNP (heterogeneous nuclear ribonucleoprotein) A1 mediates silencing of the CI cassette exon in conjunction with the guanosine-rich motifs, hnRNP H functions as an antagonist to silencing. Genome-wide analysis shows that, while this motif pattern is rarely present in human and mouse exons, those exons for which the pattern is conserved are generally found to be skipped exons. The identification of a similar arrangement of guanosine-rich motifs in transcripts of the hnRNP H family of splicing factors has implications for their co-ordinate regulation at the level of splicing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506926     DOI: 10.1042/BST0320924

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  9 in total

1.  Resonance assignments of the two N-terminal RNA recognition motifs (RRM) of the human heterogeneous nuclear ribonucleoprotein F (HnRNP F).

Authors:  Cyril Dominguez; Frédéric H-T Allain
Journal:  J Biomol NMR       Date:  2005-12       Impact factor: 2.835

2.  The hnRNPs F and H2 bind to similar sequences to influence gene expression.

Authors:  Serkan A Alkan; Kathleen Martincic; Christine Milcarek
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription.

Authors:  Jens Rauch; Eric O'Neill; Brigitte Mack; Christoph Matthias; Markus Munz; Walter Kolch; Olivier Gires
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

4.  Identification of sex-specific transcripts of the Anopheles gambiae doublesex gene.

Authors:  Christina Scali; Flaminia Catteruccia; Qiuxiang Li; Andrea Crisanti
Journal:  J Exp Biol       Date:  2005-10       Impact factor: 3.312

5.  Short, synthetic and selectively 13C-labeled RNA sequences for the NMR structure determination of protein-RNA complexes.

Authors:  Philipp Wenter; Luc Reymond; Sigrid D Auweter; Frédéric H-T Allain; Stefan Pitsch
Journal:  Nucleic Acids Res       Date:  2006-06-28       Impact factor: 16.971

6.  Complex splicing control of the human Thrombopoietin gene by intronic G runs.

Authors:  Roberto Marcucci; Francisco E Baralle; Maurizio Romano
Journal:  Nucleic Acids Res       Date:  2006-12-07       Impact factor: 16.971

7.  Associations between intronic non-B DNA structures and exon skipping.

Authors:  Zing Tsung-Yeh Tsai; Wen-Yi Chu; Jen-Hao Cheng; Huai-Kuang Tsai
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

8.  Binding of hnRNP H and U2AF65 to respective G-codes and a poly-uridine tract collaborate in the N50-5'ss selection of the REST N exon in H69 cells.

Authors:  Carlos Ortuño-Pineda; José Manuel Galindo-Rosales; José Victor Calderón-Salinas; Nicolás Villegas-Sepúlveda; Odila Saucedo-Cárdenas; Mónica De Nova-Ocampo; Jesús Valdés
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

9.  PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes.

Authors:  Erming Wang; Neviana Dimova; Franca Cambi
Journal:  Nucleic Acids Res       Date:  2007-06-12       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.